Co-Diagnostics, Inc.
CODX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -10.8% | 224% | -66.3% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 81.9% | 80.3% | 57.1% | -70.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,640.6% | -4,767.3% | -16,451.9% | -7,734.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,049.3% | -4,745% | -14,983.5% | -7,387.4% |
| EPS Diluted | -0.16 | -0.23 | -0.24 | -0.33 |
| % Growth | 30.4% | 4.2% | 27.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |